Cart
sales@molnova.com
Hederoside D2
CAS No. 20853-58-1
Hederoside D2( ——— )
Catalog No. M38959 CAS No. 20853-58-1
Cauloside C is a triterpene glycoside isolated from Caulophyllum robustum Max. Cauloside C exerts anti-inflammatory effects through the inhibition of expression of iNOS and proinflammatory cytokines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 235 | In Stock |
|
| 10MG | 376 | In Stock |
|
| 25MG | 616 | In Stock |
|
| 50MG | 888 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHederoside D2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCauloside C is a triterpene glycoside isolated from Caulophyllum robustum Max. Cauloside C exerts anti-inflammatory effects through the inhibition of expression of iNOS and proinflammatory cytokines.
-
DescriptionCauloside C is a triterpene glycoside isolated from Caulophyllum robustum Max and it exerts anti-inflammatory effects through the inhibition of expression of iNOS and proinflammatory cytokines.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number20853-58-1
-
Formula Weight766.95
-
Molecular FormulaC41H66O13
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (130.39 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee Y, et al. Anti-Inflammatory Effect of Triterpene Saponins Isolated from Blue Cohosh (Caulophyllum thalictroides). Evid Based Complement Alternat Med. 2012;2012:798192.?
molnova catalog
related products
-
CNT2 inhibitor-1
CNT2 inhibitor-1 is a potent inhibitor of concentrative nucleoside transporter 2 (CNT2; IC50: 640 nM for hCNT2).
-
Kaempferol 3,5-O-dig...
The stems of Equisetum hyemale L.
-
Ac2-26 TFA
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
